NALT

Preferred term

Creutzfeldt-Jakob Syndrome

Topic

A rare transmissible encephalopathy most prevalent between the ages of 50 and 70 years. Affected individuals may present with sleep disturbances, personality changes, ataxia, aphasia, visual loss, weakness, muscle atrophy, myoclonus, progressive dementia, and death within one year of disease onset. Pathological features include prominent cerebellar and cerebral cortical spongiform degeneration and the presence of prions.

prion diseases

bovine spongiform encephalopathy

CJD (Creutzfeldt-Jakob Disease)
Creutzfeldt Jakob Syndrome
Creutzfeldt-Jakob Disease
Jakob Creutzfeldt Disease
Jakob Creutzfeldt Syndrome
Jakob-Creutzfeldt Disease
Jakob-Creutzfeldt Syndrome
new variant Creutzfeldt-Jakob Disease
new variant Creutzfeldt-Jakob Syndrome
new variant Jakob Creutzfeldt Disease
V-CJD (Variant-Creutzfeldt-Jakob Disease)
Variant Creutzfeldt-Jakob Disease

Field 001 in MARC Authority Format

10172

Spanish

síndrome de Creutzfeldt-Jakob

URI

https://lod.nal.usda.gov/nalt/18996

Download this concept

Created 1/19/06, last modified 11/30/12